Underuse of invasive procedures among Medicaid patients with acute myocardial infarction

E F Philbin1, P A McCullough, T G DiSalvo

  • 1Division of Cardiology, Albany Medical College, (Mail Code 44), 47 New Scotland Ave, Albany, NY 12208, USA. philbie@mail.amc.edu

Insights

Medicaid patients with acute myocardial infarction receive fewer cardiac procedures. This underuse is not explained by patient demographics, health status, or care location, indicating other factors are at play.

Area of Science:

  • Cardiology
  • Health Services Research
  • Health Economics

Background:

  • Access to cardiac procedures can be influenced by insurance status.
  • Disparities in healthcare utilization exist among different patient populations.
  • Acute myocardial infarction (AMI) necessitates timely and appropriate cardiac interventions.

Purpose of the Study:

  • To investigate if underuse of cardiac procedures in acute myocardial infarction (AMI) patients with Medicaid insurance is due to patient characteristics or other factors.
  • To compare cardiac procedure utilization between Medicaid patients and those with other insurance types.

Main Methods:

  • Analysis of administrative data from 226 New York hospitals.
  • Inclusion of 11,579 individuals hospitalized with acute myocardial infarction (AMI).
  • Comparison of cardiac procedure use (cardiac catheterization, percutaneous transluminal coronary angioplasty, revascularization) between Medicaid and non-Medicaid patients, adjusting for covariates.

Main Results:

  • Medicaid patients were older, more often African American and female, and had lower incomes.
  • Medicaid patients exhibited higher rates of comorbidities including hypertension, diabetes, lung disease, renal disease, and peripheral vascular disease.
  • Even after adjusting for demographic, socioeconomic, and clinical factors, Medicaid patients were less likely to undergo cardiac catheterization, percutaneous transluminal coronary angioplasty, and revascularization.

Conclusions:

  • Factors beyond age, race, sex, income, comorbidities, and care location contribute to the lower utilization of invasive cardiac procedures among Medicaid patients.
  • The impact of Medicaid insurance on medical practice and the quality of care warrants further investigation.
  • Addressing disparities in cardiac procedure use for AMI patients is crucial for equitable healthcare outcomes.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...